Abstract:Background: In the UK, NHS hospitals receive large amounts of evidence-based recommendations for care delivery from the National Institute for Health and Care Excellence (NICE) and other organisations. Little is known about how NHS organisations implement such guidance and best practice for doing so. This study was therefore designed to examine the dissemination, decision-making, and monitoring processes for NICE interventional procedures (IP) guidance and to investigate the barriers and enablers to the implementation of such guidance. Methods: A cross-sectional survey questionnaire was developed and distributed to individuals responsible for managing the processes around NICE guidance in all 181 acute NHS hospitals in England, Scotland, Wales and Northern Ireland. A review of acute NHS hospital policies for implementing NICE guidance was also undertaken using information available in the public domain and from organisations' websites. Results: The response rate to the survey was 75 % with 135 completed surveys received. Additionally, policies from 25 % of acute NHS hospitals were identified and analysed. NHS acute hospitals typically had detailed processes in place to implement NICE guidance, although organisations recognised barriers to implementation including organisational process barriers, clinical engagement and poor targeting with a large number of guidance issued. Examples of enablers to, and good practice for, implementation of guidance were found, most notably the value of shared learning experiences between NHS hospitals. Implications for NICE were also identified. These included making improvements to the layout of guidance, signposting on the website and making better use of their shared learning platform. Conclusions: Most organisations have robust processes in place to deal with implementing guidance. However, resource limitations and the scope of guidance received by organisations create barriers relating to organisational processes, clinician engagement and financing of new procedures. Guidance implementation can be facilitated through encouragement of shared learning by organisations such as NICE and open knowledge transfer between organisations.

Introduction of Value Based Pricing May Miss Its 2014 Target, NICE Says

When the price is right: drug costing and NICE approval.

NICE to Advise Firms on How to Speed Up NHS Adoption of Their Drugs

Societal views on NICE, cancer drugs fund and value-based pricing criteria for prioritising medicines: a cross-sectional survey of 4118 adults in Great Britain

NICE Uses Wrong Comparator to Assess Cost Effectiveness of New Drugs, Report Says.

Examining the implementation of NICE guidance: cross-sectional survey of the use of NICE interventional procedures guidance by NHS Trusts

NICE is Too Generous in Approving Drugs, Analysis Says.

NICE cannot always allow healthcare professionals to prescribe the best available treatment

NHS Must Publish More Data and Value Staff More, Outgoing Chief Says

When the Price is Right: Drug Costing and NICE Approval

Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required

New Cancer Drugs Fund is Flawed Without NICE Reform, Says Roche

Only 12 of 211 Commissioning Groups Are Acting on Integrated Care, Conference Hears

Nice Sets Cap On Drugs Costing More Than 20m Pound

Is the United Kingdom (UK) medicines pricing policy failing patients? The impact of terminated National Institute for Health and Care Excellence (NICE) appraisals for multi-indication products on patients

NICE guidance: opportunity cost of clinician time needs to be quantified

The Nhs Must Change or Die

Including carer health-related quality of life in NICE health technology assessments in the United Kingdom

Choosing Drugs on Price Alone Will Stifle Innovation, Says Report

Review of the National Institute for Health and Care Excellence guidelines on chronic heart failure

NICE Sticks to Its Advice to Drop Threshold for Prescribing Statins